Millipore Sigma Vibrant Logo

586005 Thapsigargin - CAS 67526-95-8 - Calbiochem

Thapsigargin, CAS 67526-95-8, is a cell-permeable, tumor-promoting sesquiterpene lactone that releases calcium by non-competitvley inhibiting endoplasmic reticular Ca2+-ATPase (IC₅₀ = 4-13 nM).

Thapsigargin - CAS 67526-95-8 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Primary Target: endoplasmic reticular Ca2+ ATPase
View Products on Sigmaaldrich.com
586005
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
67526-95-8C₃₄H₅₀O₁₂

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
586005-1MG
Retrieving availability...
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 1 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell-permeable tumor-promoting sesquiterpene lactone that releases Ca2+ by inhibiting endoplasmic reticular Ca2+-ATPase (IC50 = 4-13 nM). Does not increase inositol phosphates and has no significant effect on protein kinase C. Increases Ca2+-dependent Na+ influx in human platelets in a dose-dependent manner. Induces apoptosis in rat thymocytes and in human hepatoma cells. Shown to induce apoptosis in alveolar rhabdomyosarcoma cells by elevating Akt-stimulated PAX3-FOXO1 phosphorylation and promoting its proteasomal degradation.
      Catalogue Number586005
      Brand Family Calbiochem®
      References
      ReferencesJothi, M., et al. 2013. Mol. Cancer Ther. In press.
      Won, J.G. and Orth, D.N. 1995. Endocrinology 136, 5399.
      Tepel, M., et al. 1994. Biochim. Biophys. Acta 1220, 248.
      Begum, N., et al. 1993. J. Biol. Chem. 268, 3352.
      Low, A.M., et al. 1993. Eur. J. Pharmacol. 230, 53.
      Tsukamoto, A. and Karneko, Y. 1993. Cell. Biol. Int. 17, 969.
      Wong, W.L., et al. 1993. Biochem. J. 289, 71.
      Glennon, M.C., et al. 1992. J. Biol. Chem. 267, 25568.
      Xu, Y., et al. 1992. J. Neurochem. 59, 2224.
      Mason, M.J., et al. 1991. J. Biol. Chem. 266, 20856.
      Thastrup, O., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 2466.
      Product Information
      CAS number67526-95-8
      ATP CompetitiveN
      FormColorless solid
      Hill FormulaC₃₄H₅₀O₁₂
      Chemical formulaC₃₄H₅₀O₁₂
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ200
      Applications
      Biological Information
      Primary Targetendoplasmic reticular Ca2+ ATPase
      Primary Target IC<sub>50</sub>4-13 nM against endoplasmic reticular Ca2+-ATPase
      Purity≥97% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38-42

      Irritating to eyes, respiratory system and skin.
      May cause sensitization by inhalation.
      S PhraseS: 36/37/39-26

      Wear suitable protective clothing, gloves and eye/face protection.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 2-3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      586005-1MG 04055977265026

      Documentation

      Thapsigargin - CAS 67526-95-8 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Thapsigargin - CAS 67526-95-8 - Calbiochem Certificates of Analysis

      TitleLot Number
      586005

      References

      Reference overview
      Jothi, M., et al. 2013. Mol. Cancer Ther. In press.
      Won, J.G. and Orth, D.N. 1995. Endocrinology 136, 5399.
      Tepel, M., et al. 1994. Biochim. Biophys. Acta 1220, 248.
      Begum, N., et al. 1993. J. Biol. Chem. 268, 3352.
      Low, A.M., et al. 1993. Eur. J. Pharmacol. 230, 53.
      Tsukamoto, A. and Karneko, Y. 1993. Cell. Biol. Int. 17, 969.
      Wong, W.L., et al. 1993. Biochem. J. 289, 71.
      Glennon, M.C., et al. 1992. J. Biol. Chem. 267, 25568.
      Xu, Y., et al. 1992. J. Neurochem. 59, 2224.
      Mason, M.J., et al. 1991. J. Biol. Chem. 266, 20856.
      Thastrup, O., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 2466.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-October-2013 JSW
      DescriptionA cell-permeable tumor-promoting sesquiterpene lactone that releases Ca2+ by inhibiting endoplasmic reticular Ca2+-ATPase. Does not increase inositol phosphates and has no significant effect on protein kinase C. Increases Ca2+-dependent Na+ influx in human platelets in a dose-dependent manner. Activates apoptosis in rat thymocytes and induces apoptosis in human hepatoma cells. Shown to induce apoptosis in alveolar rhabdomyosarcoma cells by elevating Akt-stimulated PAX3-FOXO1 phosphorylation and promoting its proteasomal degradation.
      FormColorless solid
      CAS number67526-95-8
      Chemical formulaC₃₄H₅₀O₁₂
      Structure formulaStructure formula
      Purity≥97% by TLC
      SolubilityDMSO (>1 mg/ml) or ethanol (5 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 2-3 months at -20°C.
      Toxicity Irritant
      ReferencesJothi, M., et al. 2013. Mol. Cancer Ther. In press.
      Won, J.G. and Orth, D.N. 1995. Endocrinology 136, 5399.
      Tepel, M., et al. 1994. Biochim. Biophys. Acta 1220, 248.
      Begum, N., et al. 1993. J. Biol. Chem. 268, 3352.
      Low, A.M., et al. 1993. Eur. J. Pharmacol. 230, 53.
      Tsukamoto, A. and Karneko, Y. 1993. Cell. Biol. Int. 17, 969.
      Wong, W.L., et al. 1993. Biochem. J. 289, 71.
      Glennon, M.C., et al. 1992. J. Biol. Chem. 267, 25568.
      Xu, Y., et al. 1992. J. Neurochem. 59, 2224.
      Mason, M.J., et al. 1991. J. Biol. Chem. 266, 20856.
      Thastrup, O., et al. 1990. Proc. Natl. Acad. Sci. USA 87, 2466.